Lea Harrington
Professor & Chair
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (2)
To probe drug mechanism of action (MOA) and interrogate the genetic architecture of human cells, we carried out isogenic genome-wide CRISPR/Cas9 knockout screens against 310 diverse drugs, bioactive compounds, and stress conditions. Stringent statistical correction for gene knockout fitness defects yielded a large-scale matrix of >12,000 high confidence chemical-genetic interactions (CGIs). This dataset revealed many previously unappreciated off-target effects for well-characterized compounds and novel MOAs for uncharacterized compounds. The CGI matrix uncovered dense genetic modules that yielded new biological insights into phospholipidosis, mitotic regulation, metabolism, the DNA damage response, and mTOR signaling. The dataset allowed identification of multi-drug sensitization and resistance mechanisms, inference of gene function, elaboration of cross-process connectivity, evaluation of the cell type specificity of CGIs, prediction of chemical synergism, and extensive annotation of understudied genes. This resource provides a map of the genetic landscape in human cells and a framework to help guide drug discovery.
Year:
2026
Telomere maintenance is essential for maintaining genome integrity in both normal and cancer cells. Without functional telomeres, chromosomes lose their protective structure and undergo fusion and breakage events that drive further genome instability, including cell arrest or death. One means by which this loss can be overcome in stem cells and cancer cells is via re‐addition of G‐rich telomeric repeats by the telomerase reverse transcriptase (TERT). During aging of somatic tissues, however, insufficient telomerase expression leads to a proliferative arrest called replicative senescence, which is triggered when telomeres reach a critically short threshold that induces a DNA damage response. Cancer cells express telomerase but do not entirely escape telomere instability as they often possess short telomeres; hence there is often selection for genetic alterations in the TERT promoter that result in increased telomerase expression. In this review, we discuss our current understanding of the consequences of telomere instability in cancer and aging, and outline the opportunities and challenges that lie ahead in exploiting the reliance of cells on telomere maintenance for preserving genome stability.
Year:
2022
Collaborators (15)
Sylvain Meloche
Principal Investigator
Université de Montréal
John Aitchison
University of Washington
Damien D’Amours
University of Ottawa
Vincent Archambault
Université de Montréal
Sandhya Manohar
Junior Group Leader
University of Zurich
Philippe Roux
Scientific Director
Université de Montréal
Benjamin Kwok
Associate Professor
University of Nebraska Medical Center
Katherine L B Borden
Professor
Northwestern Medicine
Mike Tyers
Senior Scientist
Hospital for Sick Children
Sylvie MADER
Professor
Université de Montréal
E. Elizabeth Patton
Chair of Functional and Translational Genomics
University of Edinburgh
Trang Hoang
Full professor
Université de Montréal
Pierre Thibault
Professor and Principal investigator
Université de Montréal
Guy Sauvageau
Professor of Medicine
Université de Montréal
Peter B. Dirks
-
Make your next move.
Prepare your application
Review drafts before you send them.